Sclerotherapy can also be performed using foamed sclerosants under ultrasound guidance to treat larger varicose veins, including the great saphenous and small saphenous veins.There is some evidence that sclerotherapy is a safe and may be an effective treatment option for improving the cosmetic appearance, reducing residual varicose veins, improving the quality of life, and reducing symptoms that may be present due to the varicose veins. There is also weak evidence that this treatment option may have a slightly higher risk of deep vein thrombosis. It is not known if sclerotherapy decreases the change that varicose veins return (recurrent varicose veins). It is also not known if the type of liquid, substance, or foam used for the sclerotherapy procedure is the most effective and comes with the lowest risk of complications.Complications of sclerotherapy are rare but can include blood clots and ulceration. Anaphylactic reactions are "extraordinarily rare but can be life-threatening," and doctors should have resuscitation equipment ready. There has been one reported case of stroke after ultrasound-guided sclerotherapy when an unusually large dose of sclerosant foam was injected. Endovenous thermal ablation
There are three kinds of endovenous thermal ablation treatment possible: laser, radiofrequency, and steam.The Australian Medical Services Advisory Committee (MSAC) in 2008 determined that endovenous laser treatment/ablation (ELA) for varicose veins "appears to be more effective in the short term, and at least as effective overall, as the comparative procedure of junction ligation and vein stripping for the treatment of varicose veins."
[3]

Epidemiology
Transient neonatal pustular melanosis occurs in as much as 15% of black newborns. [3] but in less than 1% of white newborns. [2]

See also
List of cutaneous conditions

References

1. OConnor NR, McLaughlin, MR, Ham P (2008). "Newborn Skin: Part I. Common Newborn Rashes". American Family Physician. 77 (1): 47–52. 2. Patrizi A, Neri I, Virid A, Gurioli C.(2016). "Frequent newborn skin diseases". Clinical Dermatology. 4 (3-4): 82–86. doi: 10.11138/cderm/2016.4.3.082. 3. Ghosh S. (2015). "Neonatal Pustular Dermatosis: An Overview". Indian Journal of Dermatology. 60 (2): 211. doi: 10.4103/0019-5154.152558
4. Ferrándiz C, Coroleu W, Ribera M, Lorenzo JC, Natal A (1992). "Sterile transient neonatal pustulosis is a precocious form of erythema toxicum neonatorum". Dermatology. 185:18–22. 5. Mebazaa A, Khaddar-Kort R, Cherif M, Mokni S, Haouet A, Osman B (2011). "Transient pustular eruption in neonates". Archives de Pediatrie. 18 (3) 291–293.